Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients-Reference-Cited by-同舟云学术

Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients

Published:2018-06-27 Issue:3 Volume:6 Page:57
ISSN:2226-4787
Container-title:Pharmacy
language:en
Short-container-title:Pharmacy

Author:

Palanisamy Sivanandy,Yien Emily,Shi Ling,Si Low,Qi See,Ling Laura,Lun Teng,Chen Yap

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

http://www.mdpi.com/2226-4787/6/3/57/pdf

Reference88 articles.

1. Tanzeum (Albiglutide): A once-weekly GLP-1 receptor agonist subcutaneous injection approved for the treatment of patients with type 2 diabetes;Fala;Am. Health Drug Benefits,2015

2. Type 2 Diabetes Mellitus: A Review of Current Trends

3. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Characterization of Baicalein-loaded Aquasomes: An In vitro and In silico Perspective for Diabetes Mellitus;Current Drug Discovery Technologies;2024-09

2. Systematic review of the efficacy and safety of GLP-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus;Pharmacia;2024-08-02

3. Cross-sectional analysis of the association between household food insecurity and mental health conditions in children aged 5–11 years in Canada;BMJ Open;2024-06

4. Adverse effects with semaglutide: a protocol for a systematic review with meta-analysis and trial sequential analysis;BMJ Open;2024-06

5. Designing combinational herbal drugs based on target space analysis;BMC Complementary Medicine and Therapies;2024-05-01